Sabby Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,189,700
| Closed | -$10.2M | – | 227 |
|
|
2021
Q4 | $10.2M | Buy |
2,189,700
+491,593
| +29% | +$3.05M | 2.5% | 11 |
|
|
2021
Q3 | $13M | Buy |
1,698,107
+500,131
| +42% | +$4.24M | 2.84% | 11 |
|
|
2021
Q2 | $11.6M | Buy |
1,197,976
+133,043
| +12% | +$1.06M | 2.51% | 8 |
|
|
2021
Q1 | $8.81M | Buy |
+1,064,933
| New | +$11.2M | 6.48% | 9 |
|
|
2020
Q4 | – | Sell |
-606,298
| Closed | -$4.87M | – | 189 |
|
|
2020
Q3 | $6.76M | Buy |
+606,298
| New | +$5.55M | 6.11% | 21 |
|
|
2020
Q2 | – | Sell |
-287,386
| Closed | -$1.1M | – | 149 |
|
|
2020
Q1 | $529K | Buy |
287,386
+260,208
| +957% | +$749K | 1.83% | 39 |
|
|
2019
Q4 | $92K | Buy |
+27,178
| New | +$64.8K | 0.34% | 63 |
|
|
2019
Q1 | – | Sell |
-84,536
| Closed | – | – | 157 |
|
|
2018
Q4 | $0 | Buy |
+84,536
| New | +$276K | ﹤0.01% | 164 |
|
|
2017
Q3 | – | Sell |
-17,300
| Closed | -$35K | – | 255 |
|
|
2017
Q2 | $35K | Buy |
+17,300
| New | +$33.8K | 0.02% | 205 |
|
|
2016
Q4 | – | Sell |
-20,986
| Closed | -$162K | – | 386 |
|
|
2016
Q3 | $162K | Sell |
20,986
-232,819
| -92% | -$1.57M | 0.06% | 276 |
|
|
2016
Q2 | $1.42M | Sell |
253,805
-125,995
| -33% | -$805K | 0.49% | 133 |
|
|
2016
Q1 | $2.04M | Buy |
379,800
+79,800
| +27% | +$464K | 0.41% | 97 |
|
|
2015
Q4 | $2.61M | Buy |
300,000
+132,936
| +80% | +$1.12M | 0.87% | 104 |
|
|
2015
Q3 | $1.4M | Buy |
+167,064
| New | +$2.66M | 0.28% | 202 |
|
|
2014
Q1 | – | Sell |
-222,026
| Closed | -$1.8M | – | 318 |
|
|
2013
Q4 | $1.8M | Buy |
+222,026
| New | +$1.95M | 1.07% | 91 |
|
Other funds holding SRNE
